Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Molecular Bioengineering in health ERA chair

Project description

DE EN ES FR IT PL

Promoting the integration between biomedical engineering, biology and medicine

The EU-funded MOBILIsE project aims to promote the integration between biomedical engineering, biology and medicine by emphasising interactions at the molecular level with impact on human health. It will also focus on cancer, infection, neurodegenerative diseases and tissue repair and regeneration. In this scope, the project will recruit a researcher to be appointed as the European Research Area (ERA) Chair holder at the Institute of Biomedical Engineering (INEB) in Portugal. The Chair holder will lead the research on molecular bioengineering focussing on precision medicine, more specifically on targeted therapies and molecular diagnosis. Ultimately, MOBILIsE will establish a molecular bioengineering research group that will further enhance the INEB's research excellence.

Objective

MOBILIsE aims to recruit an outstanding Researcher to act as the ERA Chair Holder to the National Institute of Biomedical Engineering (INEB). She/he will establish a new research direction in Molecular Bioengineering focused on precision medicine, namely in targeted therapies and molecular diagnosis, and create a synergic and cohesive research environment among key stakeholders (academy, research institutes, clinicians and industry) in the Porto region: the MOBILIsE hub. The MOBILIsE project will boost the translation of the design of new molecular targets to the application of diagnostic tools and therapies targeted to the major health challenges, with particular focus on cancer, infection, neurodegenerative diseases, and tissue repair/regeneration that have been explored at the institute. INEB is already recognized for its fundamental work in protein/cell-materials interactions and in the development of nanotechnology tools for targeted controlled drug delivery. Yet, the potential and projection at international level of cross-disciplinary research, like the application of nanomedicine to cancer and neurologic disorders, is still limited. This has a major impact on funding attraction, transfer of technology, and translational potential of the research developed. Hence, this project will hire an expert in Molecular Bioengineering to install an internationally competitive research group focused on precision medicine. The group will exploit nanotechnology tools to discover new molecular targets that can be explored in the design of new diagnostic and/or therapeutic systems. The MOBILIsE project will promote the integration between biomedical engineering, biology and medicine, by focusing on (vital) interactions at the molecular level with impact on human health. Ultimately, MOBILIsE aims to establish a Molecular Bioengineering research group that will facilitate critical institutional structural changes to maximize the high potential for research excellence at INEB.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.

You need to log in or register to use this function

Keywords

Programme(s)

Topic(s)

Funding Scheme

CSA - Coordination and support action

Coordinator

INEB-INSTITUTO NACIONAL DE ENGENHARIA BIOMEDICA
Net EU contribution
€ 2 478 155,00
Address
RUA ALFREDO ALLEN 208
4200 135 Porto
Portugal

See on map
Region
Continente Norte Área Metropolitana do Porto
Activity type
Research Organisations
Links
Total cost
€ 2 478 155,00

Share this page Share this page on social networks

Download Download the content of the page

Last update: 26 February 2025

My Booklet

Permalink: https://cordis.europa.eu/project/id/951723

European Union, 2025

My booklet 0 0